In conclusion, despite this study having a limited sample size and descriptive design, it allowed to evaluate and describe the frequency of BRCA1 and BRCA2 mutations in a population-based series of cases with ovarian cancer from Salento that is a large area that includes more than 1 million inhabitants. This evidence concerns the gene BRCA1 and ovarian carcinoma.